Barriers to Implementing Myopia Management Strategies in Europe: Findings from an Expert Survey Conducted via Electronic and Telephone Methods - Takeaways - MDSpire

Barriers to Implementing Myopia Management Strategies in Europe: Findings from an Expert Survey Conducted via Electronic and Telephone Methods

  • By

  • Annegret Dahlmann-Noor

  • Line Kessel

  • Wolf A. Lagrèze

  • Susana Noval

  • Jan Roelof Polling

  • Edoardo Villani

  • Dominique Brémond-Gignac

  • April 22, 2026

  • 0 min

Share

  • 1

    The European Medicines Agency approved low-concentration atropine for myopia management in children aged 3 and older.

  • 2

    Implementation strategies for myopia management vary significantly across European countries, affecting access to care.

  • 3

    Workforce numbers of eye care professionals, including ophthalmologists and optometrists, are generally low compared to the child population.

  • 4

    Prescribing rights for myopia treatments differ by country, impacting the availability of pharmacological options.

  • 5

    European guidelines for myopia management training and care standards are needed to ensure timely access to interventions.

Original Source(s)

Barriers to Implementing Myopia Management Strategies in Europe: Findings from an Expert Survey Conducted via Electronic and Telephone Methods

  • by Annegret Dahlmann-Noor, Line Kessel, Wolf A. Lagrèze, Susana Noval, Jan Roelof Polling, Edoardo Villani, Dominique Brémond-Gignac

  • April 22, 2026

Related Content

Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes

The European Myopia Network

A collaborative platform for myopia experts in Europe

Risk Factors of Myopia

Myopia is surging globally, driven by lifestyle factors, with outdoor time offering key protection